NDC 71656-021-30 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-021
- Requested NDC
- 71656-021-30
- Package NDCs from labels
- 71656-021-16, 71656-021-15, 71656-021-50, 71656-021-01, 71656-021-30, 71656-021-51, 71656-021-02
- Manufacturer
- American Health Packaging
- Effective date
- 2026-09-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - American Health Packaging | American Health Packaging | 2026-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Saptalis Pharmaceuticals, LLC | Saptalis Pharmaceuticals, LLC | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-08-24 | HUMAN PRESCRIPTION DRUG LABEL |
| POTASSIUM CHLORIDE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-01 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 CASE | SOLUTION | 10 | 5 | |
| 71656-021-02 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-15 | POTASSIUM CHLORIDE | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 71656-021-16 | POTASSIUM CHLORIDE | 473 mL in 1 BOTTLE | SOLUTION | 473 | 5 | |
| 71656-021-30 | POTASSIUM CHLORIDE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 | |
| 71656-021-50 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 10 in 1 TRAY | SOLUTION | 10 | 5 | |
| 71656-021-51 | POTASSIUM CHLORIDE | 5 in 1 CASE | SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71656-021-01 | ML - Milliliter | 71656-021 | 6bd0ebbf-a7a4-40f2-b463-9f94ddbce7be | 1 | 2024-06-10 |
| 71656-021-15 | ML - Milliliter | 71656-021 | c27304b6-be2d-4797-aac3-a530ab28e3ba | 1 | 2024-06-10 |
| 71656-021-16 | ML - Milliliter | 71656-021 | 99d9cda5-bc17-4912-b16e-3b4dd995bd14 | 1 | 2024-08-12 |
| 71656-021-30 | ML - Milliliter | 71656-021 | 0b65870e-cf13-427b-af5f-c812d5eb9e9c | 1 | 2025-05-14 |
| 71656-021-50 | ML - Milliliter | 71656-021 | b55652f8-ada5-4d3a-a114-b9e2fbac018c | 1 | 2023-12-05 |
| 71656-021-51 | ML - Milliliter | 71656-021 | 5d529fbd-3765-4e17-9818-571896c812e3 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dr Talbots Infant Pain Inflamtion Relief | ARNICA 12X,BELLIS PERENNIS 12X,CALENDULA OFFICINALIS 12X,CHAMOMILLA 12X,COFFEA CRUDA 12X,HYPERICUM 12X,MILLEFOLIUM 12X,FERRUM PHOSPHORICUM 12X,KALI MURIATICUM 6X,MAGNESIA PHOSPHORICA 6X | Talbots Pharmaceuticals Family Products, LLC. | e892c0cb-03b4-52da-e053-2995a90a0878 | 2022-09-12 | Warnings | 660YQ98I10 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Dr. Reddys Laboratories, Inc. | dda82a38-0c08-4947-99b7-915c2949bf16 | 2022-08-29 | Warnings, Adverse reactions | 312515 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Actavis Pharma, Inc. | db002ae3-f54c-40a4-9cb4-e5681bf426e3 | 2022-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Kali Muriaticum | KALI MURIATICUM | Hahnemann Laboratories, INC. | e3c8e13d-a67d-162c-e053-2a95a90abd11 | 2022-07-14 | 660YQ98I10 | |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| KALIUM MURIATICUM 6X | POTASSIUM CHLORIDE | Seroyal USA | 22c95b6a-dd5d-476e-e054-00144ff8d46c | 2022-07-07 | Warnings | 660YQ98I10 |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Cardioplegic Solution | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Fresenius Kabi, USA, LLC | eb360dc4-88d6-4b28-9b61-bc359e16bd22 | 2022-05-27 | Warnings, Adverse reactions | 660YQ98I10 |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL B22547B95K | |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe Mexico, S.A. de C.V. | 3e2e5f52-db54-4635-83a8-a67a683c093c | 2022-03-22 | Warnings | 660YQ98I10 |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe North America, Inc. | 94de9ce3-6ee9-4322-bda2-0b4391f09d87 | 2022-03-22 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | B. Braun Medical Inc. | ab67b151-8368-4321-b562-bad5eff7b740 | 2022-02-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | a63da38d-1fea-4ee0-a70b-55c891a5ebcc | 2022-02-11 | B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | ac8971a9-36d0-43c9-9121-ba5e58c28bed | 2022-02-11 | B22547B95K | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.